493 related articles for article (PubMed ID: 18250415)
1. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
2. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
3. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
[TBL] [Abstract][Full Text] [Related]
4. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
5. Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model.
Zhao M; Luo M; Xie Y; Jiang H; Cagliero C; Li N; Ye H; Wu M; Hao S; Sun T; Yang H; Zhang M; Lin T; Lu H; Zhu J
Biomed Pharmacother; 2019 Apr; 112():108677. PubMed ID: 30798123
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction of post-selection CD8 thymocyte proliferation in IL-15Rα deficient mice.
Chow KP; Qiu JT; Lee JM; Hsu SL; Yang SC; Wu NN; Huang W; Wu TS
PLoS One; 2012; 7(3):e33152. PubMed ID: 22448237
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J; Monie A; Hung CF; Wu TC
J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
[TBL] [Abstract][Full Text] [Related]
8. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
9. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.
Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ
Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634
[TBL] [Abstract][Full Text] [Related]
10. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.
Stoklasek TA; Colpitts SL; Smilowitz HM; Lefrançois L
J Immunol; 2010 Dec; 185(11):6857-65. PubMed ID: 21041729
[TBL] [Abstract][Full Text] [Related]
11. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
12. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells.
Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS
J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310
[TBL] [Abstract][Full Text] [Related]
13. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.
Berard M; Brandt K; Bulfone-Paus S; Tough DF
J Immunol; 2003 May; 170(10):5018-26. PubMed ID: 12734346
[TBL] [Abstract][Full Text] [Related]
14. Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
Zhang M; Ju W; Yao Z; Yu P; Wei BR; Simpson RM; Waitz R; Fassò M; Allison JP; Waldmann TA
J Immunol; 2012 Jun; 188(12):6156-64. PubMed ID: 22593619
[TBL] [Abstract][Full Text] [Related]
15. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
Dhanji S; Teh HS
J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells.
Gasser S; Corthésy P; Beerman F; MacDonald HR; Nabholz M
J Immunol; 2000 Jun; 164(11):5659-67. PubMed ID: 10820241
[TBL] [Abstract][Full Text] [Related]
17. Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα.
Sato N; Sabzevari H; Fu S; Ju W; Petrus MN; Bamford RN; Waldmann TA; Tagaya Y
Blood; 2011 Apr; 117(15):4032-40. PubMed ID: 21304101
[TBL] [Abstract][Full Text] [Related]
18. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
19. Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.
Chertova E; Bergamaschi C; Chertov O; Sowder R; Bear J; Roser JD; Beach RK; Lifson JD; Felber BK; Pavlakis GN
J Biol Chem; 2013 Jun; 288(25):18093-103. PubMed ID: 23649624
[TBL] [Abstract][Full Text] [Related]
20. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]